Tag Archives: Women’s

Weekly Roundup for JUNE 28, 2019: Recent Publications in Women’s Mental Health

Ketamine is the hot new antidepressant.  It has been shown to work quickly in patients with severe depression and can rapidly reduce suicidal ideation.  However, these studies have not been conducted in perinatal women; this group of women is typically excluded from clinical trials because there is typically very little information on the reproductive safety… Read More »

Brigham and Women’s finds doctors sleep more when hours are cut

Getting a good night’s sleep is important for everyone — including physicians. In 2011, the Accreditation Council for Graduate Medical Education (ACGME) set a limit on first-year resident physician shifts of 16 or fewer continuous hours of work. This policy change was based primarily on the results of studies comparing outcomes for first-year residents who… Read More »

Weekly Roundup for MARCH 22, 2019: Recent Publications in Women’s Mental Health

The excitement over the FDA approval of brexanolone (to be marketed as Zulresso) is a good place to start this week’s roundup.  Brexanolone is a derivative of the neurosteroid allopregnanolone, and, while Zulpresso was approved specifically for the treatment of postpartum depression, there is considerable research to indicate that the modulation of neurosteroid systems may… Read More »